New Mexico Educational Retirement Board’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-5,450
Closed -$446K 910
2021
Q2
$446K Buy
5,450
+962
+21% +$80K 0.02% 882
2021
Q1
$427K Hold
4,488
0.02% 862
2020
Q4
$278K Sell
4,488
-802
-15% -$45.7K 0.01% 889
2020
Q3
$315K Sell
5,290
-962
-15% -$65.6K 0.01% 838
2020
Q2
$436K Hold
6,252
0.02% 780
2020
Q1
$284K Buy
6,252
+641
+11% +$36.3K 0.02% 803
2019
Q4
$365K Hold
5,611
0.02% 846
2019
Q3
$348K Hold
5,611
0.02% 832
2019
Q2
$400K Sell
5,611
-1,282
-19% -$94.4K 0.02% 817
2019
Q1
$541K Hold
6,893
0.02% 770
2018
Q4
$584K Buy
+6,893
New +$735K 0.03% 704

Other funds holding LGND

New Mexico Educational Retirement Board's LGND Position: Q3 2021 in Review

New Mexico Educational Retirement Board sold out of Ligand Pharmaceuticals (LGND) in Q3 2021, closing a stake of 5,450 shares — an estimated $446K sold.

New Mexico Educational Retirement Board first reported a position in LGND in Q4 2018 and held it in 11 quarters. The position peaked at $584K in Q4 2018. 207 funds tracked by Wall St. Rank hold LGND as of Q3 2021.

  • New Mexico Educational Retirement Board reported no remaining Ligand Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • New Mexico Educational Retirement Board sold 5,450 Ligand Pharmaceuticals shares in Q3 2021, an estimated $446K.
  • New Mexico Educational Retirement Board first reported a position in Ligand Pharmaceuticals in Q4 2018 and held it in 11 quarters.
  • New Mexico Educational Retirement Board's Ligand Pharmaceuticals position peaked at $584K in Q4 2018.
  • 207 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q3 2021.

Based on New Mexico Educational Retirement Board's 13F filing for Q3 2021, filed 19 Oct 2021.